BECKY WATSON: Open Payments
NPI 1760116081 · MOREHEAD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 14 payments from 10 companies in 2025. Trend: 2023 $142 · 2024 $241 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $36 |
| Alkermes, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Braeburn Inc. | 1 | $14 |
Products named: REXULTI, Auvelity, CAPLYTA, ARISTADA, HETLIOZ, UZEDY, AUSTEDO XR, VRAYLAR.
Industry payments across KY — which companies pay providers there.
